Literature DB >> 2870236

Tamoxifen and non-malignant indications.

J M Diver, I M Jackson, J D Fitzgerald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2870236     DOI： 10.1016/s0140-6736(86)91116-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  A breast pre-cancer test? Preliminary results based on a breast temperature rhythm abnormality during the menstrual cycle.

Authors:  H W Simpson
Journal:  Breast Cancer Res Treat       Date:  1990-07       Impact factor: 4.872

2.  Studies of tamoxifen as a promoter of hepatocarcinogenesis in female Fischer F344 rats.

Authors:  Y P Dragan; S Fahey; K Street; J Vaughan; V C Jordan; H C Pitot
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

3.  Nanotamoxifen Delivery System: Toxicity Assessment After Oral Administration and Biodistribution Study After Intravenous Delivery of Radiolabeled Nanotamoxifen.

Authors:  Jaya Shukla; Amit Kumar Dinda; Abhay Krishna Srivastava; Kamna Srivastava; Bhagwant Rai Mittal; Guru Pad Bandopadhyaya
Journal:  World J Nucl Med       Date:  2016 Jan-Apr
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.